bf/NASDAQ:RLMD_icon.png

COM:RELMADA

Relmada Therapeutics, Inc.

  • Stock

Last Close

3.50

31/10 20:00

Market Cap

128.54M

Beta: -

Volume Today

67.59K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
4.87K
-
3.75K
-
1.26K
66.47%
gross profit
-4.87K
-
-3.75K
-
-1.26K
66.47%
selling and marketing expenses
12.31M
-
general and administrative expenses
9.23M
-
10.01M
8.48%
5.93M
40.80%
3.97M
32.92%
5.70M
43.48%
7.25K
99.87%
24.87M
342,885.23%
35.08M
41.08%
47.93M
36.61%
36.59M
23.66%
selling general and administrative expenses
9.23M
-
10.01M
8.48%
5.93M
40.80%
3.97M
32.92%
5.70M
43.48%
7.25K
99.87%
24.87M
342,885.23%
35.08M
41.08%
47.93M
36.61%
48.89M
2.02%
research and development expenses
7.87M
-
6.21M
21.16%
1.29M
79.16%
2.94M
127.49%
7.02M
138.72%
7.86K
99.89%
35.97M
457,600.19%
90.62M
151.92%
113.32M
25.05%
54.81M
51.64%
other expenses
130.27K
-
216.21K
65.97%
2.35K
98.91%
6.35M
-
cost and expenses
17.10M
-
16.22M
5.17%
7.22M
55.48%
6.92M
4.17%
12.73M
84.00%
15.11K
99.88%
60.84M
402,565.12%
125.70M
106.62%
161.25M
28.28%
103.70M
35.69%
operating expenses
17.10M
-
16.22M
5.17%
7.22M
55.48%
6.92M
4.17%
12.73M
84.00%
15.11K
99.88%
60.84M
402,565.12%
125.70M
106.62%
161.25M
28.28%
103.70M
35.69%
interest expense
4.92K
-
1.34M
-
ebitda
-13.38M
-
-29.27M
118.76%
-7.85M
73.18%
-6.21M
20.95%
-8.89M
43.31%
-15.10K
99.83%
-60.82M
402,536.11%
-124.45M
104.63%
-156.44M
25.70%
-103.70M
33.71%
operating income
-17.10M
-
-16.22M
5.17%
-7.22M
55.48%
-6.92M
4.17%
-12.73M
84.00%
-15.11K
99.88%
-60.84M
402,556.83%
-125.70M
106.62%
-161.25M
28.28%
-103.70M
35.69%
depreciation and amortization
9.26K
-
54.82K
492.25%
85.27K
55.55%
2.63K
96.92%
4.87K
85.38%
4.36
99.91%
3.75K
85,895.87%
1.26K
66.47%
4.81M
381,917.25%
total other income expenses net
-3.71M
-
13.24M
456.82%
932.86K
92.95%
-706.55K
175.74%
-3.83M
441.94%
104.11
100.00%
-16.95K
16,376.70%
-1.25M
7,260.99%
1.55M
223.92%
4.91M
217.66%
income before tax
-20.80M
-
-2.97M
85.70%
-6.29M
111.33%
-8.96M
42.54%
-17.32M
93.26%
-15.01K
99.91%
-59.46M
396,138.62%
-125.75M
111.50%
-157.04M
24.88%
-98.79M
37.09%
income tax expense
3.70M
-
-13.11M
453.93%
-716.10K
94.54%
2.05M
385.68%
4.59M
124.38%
-1.38M
-
48.32K
103.50%
-2.66M
5,604.12%
net income
-20.80M
-
-2.97M
85.70%
-6.29M
111.33%
-8.96M
42.54%
-17.32M
93.26%
-15.01K
99.91%
-59.46M
396,138.62%
-125.75M
111.50%
-157.04M
24.88%
-98.79M
37.09%
weighted average shs out
2.49M
-
2.90M
16.68%
3.02M
4.10%
3.14M
3.90%
6.31M
101.25%
9.23K
99.85%
15.59M
168,869.86%
17.55M
12.56%
29.63M
68.80%
30.10M
1.59%
weighted average shs out dil
2.49M
-
2.90M
16.68%
3.02M
4.10%
3.14M
3.90%
6.31M
101.25%
9.23K
99.85%
15.59M
168,867.66%
17.55M
12.56%
29.63M
68.80%
30.10M
1.59%
eps
-8.37
-
-1.03
87.69%
-2.08
101.94%
-2.86
37.50%
-2.74
4.20%
-1.63
40.51%
-3.81
133.74%
-7.16
87.93%
-5.30
25.98%
-3.28
38.11%
epsdiluted
-8.37
-
-1.03
87.69%
-2.08
101.94%
-2.86
37.50%
-2.74
4.20%
-1.63
40.51%
-3.81
133.74%
-7.16
87.93%
-5.30
25.98%
-3.28
38.11%

All numbers in (except ratios and percentages)